Role of epigenetic regulation in myocardial ischemia/reperfusion injury

K Wang, Y Li, T Qiang, J Chen, X Wang - Pharmacological Research, 2021 - Elsevier
Nowadays acute myocardial infarction (AMI) is a serious cardiovascular disease threatening
the human life and health worldwide. The most effective treatment is to quickly restore …

HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis

X Lyu, M Hu, J Peng, X Zhang… - … advances in chronic …, 2019 - journals.sagepub.com
Fibrosis usually results from dysregulated wound repair and is characterized by excessive
scar tissue. It is a complex process with unclear mechanisms. Accumulating evidence …

Proteostasis in cardiac health and disease

RH Henning, BJJM Brundel - Nature Reviews Cardiology, 2017 - nature.com
The incidence and prevalence of cardiac diseases, which are the main cause of death
worldwide, are likely to increase because of population ageing. Prevailing theories about …

Therapeutic potential for HDAC inhibitors in the heart

TA McKinsey - Annual review of pharmacology and toxicology, 2012 - annualreviews.org
Reversible protein acetylation provides a central mechanism for controlling gene expression
and cellular signaling events. Two pharmacological inhibitors of protein deacetylation are …

Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia

S Chiappalupi, G Sorci, A Vukasinovic… - Journal of cachexia …, 2020 - Wiley Online Library
Background Cachexia, a multifactorial syndrome affecting more than 50% of patients with
advanced cancer and responsible for~ 20% of cancer‐associated deaths, is still a poorly …

Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes

SM Williams, L Golden-Mason, BS Ferguson… - Journal of molecular and …, 2014 - Elsevier
Fibrosis, which is defined as excessive accumulation of fibrous connective tissue,
contributes to the pathogenesis of numerous diseases involving diverse organ systems …

Activation of histone deacetylase-6 induces contractile dysfunction through derailment of α-tubulin proteostasis in experimental and human atrial fibrillation

D Zhang, CT Wu, XY Qi, RAM Meijering… - Circulation, 2014 - Am Heart Assoc
Background—Atrial fibrillation (AF) is characterized by structural remodeling, contractile
dysfunction, and AF progression. Histone deacetylases (HDACs) influence acetylation of …

Development and therapeutic implications of selective histone deacetylase 6 inhibitors

JH Kalin, JA Bergman - Journal of medicinal chemistry, 2013 - ACS Publications
This Perspective provides an in depth look at the numerous disease states in which histone
deacetylase 6 (HDAC6) has been implicated. The physiological pathways, protein–protein …

Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin

D Kaluza, J Kroll, S Gesierich, TP Yao, RA Boon… - The EMBO …, 2011 - embopress.org
Histone deacetylases (HDACs) deacetylate histones and non‐histone proteins, thereby
affecting protein activity and gene expression. The regulation and function of the cytoplasmic …

Hypertension-driven regulatory T-cell perturbations accelerate myocardial ischemia-reperfusion injury

X Sun, Y Feng, C Gong, X Bao, Z Wei, L Chang… - …, 2023 - Am Heart Assoc
BACKGROUND: Patients with a history of hypertension have elevated inflammation and a
worse prognosis after acute myocardial infarction (AMI). Regulatory T cells (Tregs) are …